22 January 2020

The Access to Medicines Task Force of the Association of European Cancer Leagues (ECL) and the European Organisation for Research and Treatment of Cancer (EORTC) strongly welcome today’s Judgment by the Court of Justice of the European Union (CJEU) which confirmed the right of access to documents related to the marketing authorisation application of medicinal products. Clinical study reports have been publicly accessible since 2010, and starting from 2016, the European Medicines Agency (EMA) has been systematically publishing these reports on its website.